NCT06909981Not yet recruiting
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The main goal of this pilot study is to understand the impact of a mobile lung cancer screening clinics in individuals from neighborhoods and communities with less access to resources in Boston, Massachusetts who are at high risk for lung cancer. A secondary goal of this pilot study is to understand how social determinants of health impact these neighborhoods and communities. Another secondary goal of this pilot study is to see if video recording of participants speaking to their future selves and sending the videos back to participants to encourage them to get lung cancer screening after one year can be administered in a mobile lung cancer screening setting. The questions this study aims to answer are: * Is mobile lung cancer screening is feasible and acceptable? * Is collecting social needs data during the mobile lung cancer screening clinics feasible? * Is creating video recordings of patients encouraging their future selves to get lung cancer screening after one year feasible? Participants will: * Complete an intake survey, providing information about their demographic, medical, and social needs information. * Undergo a shared decision-making conversation to determine whether lung cancer screening should be done. * Undergo lung cancer screening. * Undergo a debriefing conversation and fill out an acceptability survey. * Record a video speaking to their future selves about the importance of annual lung cancer screening, with the video to be sent back to them after roughly one year. * Undergo a semi-structured phone interview between four and eight weeks after lung cancer screening date.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- First submitted
- 21 Mar 2025
- Start date
- 1 May 2026
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Brigham and Women's Hospital
- Diseases
- Lung cancer
- NCT number
- NCT06909981
What you commit to
- Study type: Interventional
- Planned participants: 125
- From 1 May 2026 to the primary completion date, 1 Nov 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous diagnosis of lung cancer.
Other illness
- Has a tobacco smoking history of less than 20 pack years.
Age
- Adults/children less than 50 years, or greater than 80 years of age.
Other
- Has never smoked tobacco.
- Has smoked tobacco but quit more than 15 years ago.
- Presence of major comorbidity(ies) that could prevent treatment.
- In the opinion of the investigator, the subject is not an appropriate candidate for the study.
Who the study is looking for
- Ability to understand and the willingness to sign a written informed consent document prior to any study-related procedures.
- Willing to undergo treatment.
- Adults between the ages of 50 and 80 years.
- No recent CT imaging within the last year.
- Currently smokes tobacco or has quit smoking tobacco within the past 15 years.
- Has a tobacco smoking history of at least 20 pack years (i.e. one pack per day for the last 20 years or equivalent).
- Has never been diagnosed with lung cancer.
Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.